Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods

被引:147
作者
Dunn, G
Maracy, M
Tomenson, B
机构
[1] Univ Manchester, Biostat Grp, Div Epidemiol & Hlth Sci, Manchester M13 9PT, Lancs, England
[2] Univ Isfahan, Fac Med, Esfahan, Iran
[3] Univ Manchester, Sch Med, Div Psychiat, Manchester M13 9PT, Lancs, England
关键词
D O I
10.1191/0962280205sm403oa
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Perfectly implemented randomized clinical trials, particularly of complex interventions, are extremely rare. Almost always they are characterized by imperfect adherence to the randomly allocated treatment and variable amounts of missing outcome data. Here we start by describing a wide variety of examples and then introduce instrumental variable methods for the analysis of such trials. We concentrate mainly on situations in which compliance is all or nothing ( either the patient receives the allocated treatment or they do not - in the latter case they may receive no treatment or a treatment other than the one allocated). The main purpose of the review is to illustrate the use of latent class ( finite mixture) models, using maximum likelihood, for complier-average causal effect estimation under varying assumptions concerning the mechanism of the missing outcome data.
引用
收藏
页码:369 / 395
页数:27
相关论文
共 67 条
[1]  
Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629
[2]   2-STAGE LEAST-SQUARES ESTIMATION OF AVERAGE CAUSAL EFFECTS IN MODELS WITH VARIABLE TREATMENT INTENSITY [J].
ANGRIST, JD ;
IMBENS, GW .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1995, 90 (430) :431-442
[3]  
[Anonymous], 2003, Stata Statistical Software
[4]  
ASBERG M, 1978, ACTA PSYCHIAT SCAN S, V271
[5]   Analyzing a randomized cancer prevention trial with a missing binary outcome, an auxiliary variable, and all-or-none compliance [J].
Baker, SG .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2000, 95 (449) :43-50
[6]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[7]   ACCOUNTING FOR NO-SHOWS IN EXPERIMENTAL EVALUATION DESIGNS [J].
BLOOM, HS .
EVALUATION REVIEW, 1984, 8 (02) :225-246
[8]   Estimating a treatment effect in survival studies in which patients switch treatment [J].
Branson, M ;
Whitehead, J .
STATISTICS IN MEDICINE, 2002, 21 (17) :2449-2463
[9]  
Creed F, 1997, BRIT MED J, V314, P1381
[10]  
Cuzick J, 1997, STAT MED, V16, P1017, DOI 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO